Clinical utility of circulating miR-371a-3p for the management of patients with intracranial malignant germ cell tumors.

This series highlights the potential for microRNA quantification to assist the noninvasive diagnosis, prognostication, and management for patients with intracranial malignant GCTs. Serum and CSF should be collected routinely as part of future studies to facilitate the extension of these findings to larger patient cohorts.